PATRIZI, Ornella
 Distribuzione geografica
Continente #
NA - Nord America 1.197
EU - Europa 691
AS - Asia 674
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
AF - Africa 2
SA - Sud America 1
Totale 2.573
Nazione #
US - Stati Uniti d'America 1.194
CN - Cina 539
PL - Polonia 293
IT - Italia 124
UA - Ucraina 107
SG - Singapore 61
FR - Francia 49
DE - Germania 36
HK - Hong Kong 33
GB - Regno Unito 25
IE - Irlanda 20
FI - Finlandia 19
TR - Turchia 15
IN - India 9
VN - Vietnam 8
SE - Svezia 7
ID - Indonesia 6
EU - Europa 5
NL - Olanda 5
BE - Belgio 4
AU - Australia 3
CA - Canada 3
CZ - Repubblica Ceca 2
JP - Giappone 2
MU - Mauritius 2
AR - Argentina 1
IR - Iran 1
Totale 2.573
Città #
Shenzhen 403
Warsaw 293
Fairfield 193
Houston 116
Woodbridge 106
Brescia 100
Ashburn 92
Cambridge 87
Jacksonville 77
Seattle 75
Wilmington 73
Chandler 68
Singapore 48
New York 42
Ann Arbor 39
Princeton 36
Hong Kong 33
Beijing 32
Dearborn 27
Nanjing 25
Dublin 20
Istanbul 14
Nanchang 11
Helsinki 10
Shenyang 10
Dong Ket 8
Jinan 8
Lancaster 7
Changsha 6
Des Moines 6
Jakarta 6
London 6
San Diego 6
Taizhou 6
Tianjin 6
Jiaxing 4
San Francisco 4
Shanghai 4
Zhengzhou 4
Hebei 3
Kilburn 3
Phoenix 3
Toronto 3
Brussels 2
Charlotte 2
Hangzhou 2
Leawood 2
Los Angeles 2
Milan 2
Munich 2
Orange 2
San Benedetto Po 2
Sydney 2
Waanrode 2
Washington 2
Ardabil 1
Baotou 1
Boardman 1
Brno 1
Brooklyn 1
Canberra 1
Changchun 1
Chicago 1
Chiswick 1
Frankfurt am Main 1
Fremont 1
Glendale 1
Gravedona 1
Haikou 1
Lappeenranta 1
Las Vegas 1
Ningbo 1
Olomouc 1
Palermiti 1
Poncarale 1
Redmond 1
Rezzato 1
Salerno 1
San Mateo 1
Santa Clara 1
Tokyo 1
Verona 1
Vobarno 1
Wenzhou 1
Xian 1
Totale 2.177
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 519
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 287
NFKB1 regulates human NK cell maturation and effector functions 279
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 157
The RAC2-PI3K axis regulates human NK cell maturation and function 154
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 143
CTLA-4 regulates human Natural Killer cell effector functions 136
Inherited DOCK2 deficiency in patients with early-onset invasive infections 127
Effects of opioid therapy on human natural killer cells. 121
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 112
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 109
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 106
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 85
Screening genetico per determinare la frequenza di grosse delezioni nei geni SDHx e VHL in una coorte italiana di pazienti affetti da Feocromocitoma/Paraganglioma. 74
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 73
P85α is an intrinsic regulator of human natural killer cell effector functions 69
Natural killer cell impairment in ovarian clear cell carcinoma 51
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 36
Totale 2.638
Categoria #
all - tutte 9.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020383 0 0 0 0 39 67 58 61 45 64 23 26
2020/2021452 10 31 7 142 23 35 12 35 49 44 47 17
2021/2022229 27 30 5 13 1 6 10 13 8 31 15 70
2022/2023212 50 0 2 14 17 49 1 24 28 1 11 15
2023/2024582 19 6 419 5 8 53 8 8 34 2 0 20
2024/202585 1 1 0 51 32 0 0 0 0 0 0 0
Totale 2.638